DIFF Main Group
A61L 33/00 Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
Introduced: January 1985
Of 9 combined children, 4 exist in both systems.
3 codes are CPC-only extensions, 2 exist only in IPC.
2 shared codes have differing titles between IPC and CPC.
IPC defines codes here since 2000.
Child Classifications
Navigate with arrow keys, Enter to open
- A61L 33/04 Use of organic materials, e.g. acetylsalicylic acid since 2000 IPC+CPC Available in IPC and CPC
- A61L 33/06 Use of macromolecular materials (grafting of a monomer onto the substrate A61L33/0088) since 2000 +3 CPC IPC+CPC Available in IPC and CPC
- A61L 33/14 Use of fibrinolytic agents or platelet aggregation inhibitors since 2000 IPC only IPC only
- A61L 33/18 Use of ingredients of undetermined constitution or reaction products thereof since 2000 IPC+CPC Available in IPC and CPC
Top Applicants
Top Applicants (IPC)
Class A61,2013–2023, worldwide · Source: EPO PATSTAT
- PHILIPS ELECTRONICS NL 18,523
- NOVARTIS CH 14,253
- COVIDIEN US 13,953
- ROCHE CH 12,005
- CHINESE ACADEMY OF SCIENCES 11,955
- UNIVERSITY OF CALIFORNIA US 11,692
- HARVARD UNIVERSITY US 11,596
- L'OREAL FR 11,593
- P&G (PROCTER & GAMBLE COMPANY) US 11,297
- OLYMPUS CORPORATION JP 9,594
Top Applicants (CPC)
Class A61,2013–2023, worldwide · Source: EPO PATSTAT
- PHILIPS ELECTRONICS NL 20,621
- NOVARTIS CH 15,792
- ROCHE CH 14,303
- COVIDIEN US 13,862
- HARVARD UNIVERSITY US 13,454
- UNIVERSITY OF CALIFORNIA US 12,798
- P&G (PROCTER & GAMBLE COMPANY) US 12,140
- L'OREAL FR 11,800
- OLYMPUS CORPORATION JP 9,894
- BOSTON SCIENTIFIC SCIMED US 9,513